Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pharmacoepidemiology and Drug Safety

• Publication date

  2015-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pds.3660PMID 24923811PMCID PMC4265308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta‐analysis

  2014cited by this paper
• Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer

  2014cited by this paper
• Standards of Medical Care in Diabetes

  2014cited by this paper
• Association Between Metformin Therapy and Mortality After Breast Cancer

  2013cited by this paper
• Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients.

  2013cited by this paper
• Patient Characteristics Associated with Medication Adherence

  2013cited by this paper
• Use of Metformin and Survival of Diabetic Women with Breast Cancer

  2013cited by this paper
• Frequent Antibiotic Use and Second Breast Cancer Events

  2013cited by this paper
• Diabetes, metformin, and breast cancer in postmenopausal women.

  2012cited by this paper
• Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis.

  2012cited by this paper
• Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer.

  2012cited by this paper
• Diabetes and breast cancer risk: a meta-analysis

  2012cited by this paper
• Standards of Medical Care in Diabetes—2013

  2012cited by this paper
• Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61

  2011cited by this paper
• Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature.

  2011cited by this paper
• Multimorbidity: an issue of growing importance for oncologists.

  2011cited by this paper
• Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

  2011cited by this paper
• Prevention, Screening, and Surveillance Care for Breast Cancer Survivors Compared With Controls: Changes from 1998 to 2002

  2010cited by this paper
• Diabetes and Cancer

  2010cited by this paper
• Metformin: A Therapeutic Opportunity in Breast Cancer

  2010cited by this paper
• Relationship between diabetes and risk of second primary contralateral breast cancer

  2010cited by this paper
• Medication Adherence: Its Importance in Cardiovascular Outcomes

  2009cited by this paper
• Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002.

  2009cited by this paper
• Estimating the impact of the discontinuation of medical interventions on health outcomes.

  2009cited by this paper
• Diabetes and cancer.

  2009cited by this paper
• Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006

  2009cited by this paper
• Interventions for enhancing medication adherence.

  2008cited by this paper
• Interventions for enhancing medication adherence.

  2008cited by this paper
• Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.

  2008cited by this paper
• Interventions for enhancing medication adherence (Review)

  2008cited by this paper
• Diabetes mellitus and risk of breast cancer: A meta‐analysis

  2007cited by this paper
• Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis

  2007cited by this paper
• A Refill Adherence Algorithm for Multiple Short Intervals to Estimate Refill Compliance (ReComp)

  2007cited by this paper
• From cancer patient to cancer survivor : lost in transition

  2006cited by this paper
• Relationship of Oral Antihyperglycemic (Sulfonylurea or Metformin) Medication Adherence and Hemoglobin A1c Goal Attainment for HMO Patients Enrolled in a Diabetes Disease Management Program

  2006cited by this paper
• Methods for evaluation of medication adherence and persistence using automated databases

  2006cited by this paper
• Standards of Medical Care in Diabetes: Response to Power

  2006cited by this paper
• Standards of medical care in diabetes.

  2006cited by this paper
• Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer

  2005cited by this paper
• Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.

  2005cited by this paper
• Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults.

  2004cited by this paper
• A Population‐Based Osteoporosis Screening Program: Who Does Not Participate, and What Are the Consequences?

  2004cited by this paper
• Impact of Healthcare Delivery System on Where HMO-Enrolled Seniors Purchase Medications

  2004cited by this paper
• Costs and utilization associated with pharmaceutical adherence in a diabetic population.

  2004cited by this paper
• Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes.

  2004cited by this paper
• Abnormal glucose tolerance and the risk of cancer death in the United States.

  2003cited by this paper
• Chronic care clinics for diabetes in primary care: a system-wide randomized trial.

  2001cited by this paper
• A biopsychosocial model of glycemic control in diabetes: stress, coping and regimen adherence.

  1999cited by this paper
• A population-based approach to diabetes management in a primary care setting: early results and lessons learned.

  1998cited by this paper
• Multiple significance tests: the Bonferroni method

  1995cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992cited by this paper
• [Diabetes and cancer].

  1956cited by this paper

• Changes in compliance with cardiovascular medication after a breast cancer diagnosis: a latent class trajectory analysis using French nationwide data

  2026cites this paper
• New‐onset prediabetes/diabetes worsens overall survival in patients with cancer: A real‐world retrospective cohort study

  2025cites this paper
• Understanding the Causes of Nonadherence to Chronic Medications Among Patients With Cancer and Multimorbidity: A Qualitative Study.

  2025cites this paper
• Association of Race/Ethnicity with Diabetes Medication Beliefs and Self-Management Behaviors in Breast Cancer Survivors

  2025cites this paper
• Identification of factors associated with non-adherence to oral endocrine therapy in breast cancer patients of low socioeconomic status: a single centre retrospective study

  2025cites this paper
• Adherence to Antidiabetic Medication and Cardiovascular Outcomes in Cancer Patients: A Nationwide Population-Based Cohort Study

  2025cites this paper
• Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approaches.

  2024cites this paper
• Impact of Breast Cancer on Cardiometabolic Health in Spanish Women ≥50 Years with Pre-Existing Type 2 Diabetes Mellitus

  2024influential citation
• Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study

  2024influential citation
• Does Diabetes Mellitus Increase Radiotherapy/ Chemoradiotherapy Acute Toxicities?

  2023cites this paper
• Analysis of the Incidence of Type 2 Diabetes, Requirement of Insulin Treatment, and Diabetes-Related Complications among Patients with Cancer

  2023cites this paper
• Secondary Prevention of Cardiovascular Disease: Unrecognized Opportunity to Improve Survival in Cancer Patients.

  2023cites this paper
• Diabetes mellitus in long‐term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population‐based study

  2023influential citation
• Adherence to Sulfonylureas in Comparison to Metformin among T2DM Patients: A Systematic Review and Meta-Analysis

  2022cites this paper
• Characterizing Beliefs About Breast Cancer and Comorbid Diabetes After Cancer Treatment.

  2022cites this paper
• Ethnic disparities in medication adherence? A systematic review examining the association between ethnicity and antidiabetic medication adherence

  2022cites this paper
• Adherence to cardiovascular disease risk factor medications among patients with cancer: a systematic review

  2022influential citation
• Providers’ mediating role for medication adherence among cancer survivors

  2021cites this paper
• Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis

  2021cites this paper
• The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6 months post-chemotherapy

  2021cites this paper
• Changes in chronic medication adherence in older adults with cancer versus matched cancer-free cohorts.

  2020cites this paper
• Impact of oral oncolytic initiation on medication adherence for pre-existing comorbid chronic conditions

  2020cites this paper
• Medication Adherence in Patients with Glaucoma After Cancer Diagnosis.

  2020cites this paper
• Diabetes care management patterns before and after a cancer diagnosis: A SEER‐Medicare matched cohort study

  2020cites this paper
• Improving health engagement and lifestyle management for breast cancer survivors with diabetes.

  2020cites this paper
• Drug price, dosage and safety: Real-world evidence of oral hypoglycemic agents.

  2019cites this paper
• Determining the Impact of a Cancer Diagnosis on Diabetes Management

  2019cites this paper
• Interrupted time series analysis on first cardiovascular disease hospitalization for adherence to lipid‐lowering therapy

  2019cites this paper
• Communicating health information and improving coordination with primary care (CHIIP): Rationale and design of a randomized cardiovascular health promotion trial for adult survivors of childhood cancer.

  2019cites this paper
• Prostate cancer and subsequent nutritional outcomes: the role of diagnosis and treatment

  2019cites this paper
• Diabetes and differences in detection of incident invasive breast cancer

  2019cites this paper
• Impact of cancer diagnosis on persistence of oral antidiabetic drugs.

  2018cites this paper
• Quality of diabetes care in cancer: a systematic review

  2018influential citation
• Preventable Diabetic Complications After a Cancer Diagnosis in Patients With Diabetes: A Population-Based Cohort Study

  2018cites this paper
• Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus

  2018cites this paper
• Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer

  2018cites this paper
• A Diabetes Pay-for-Performance Program and Risks of Cancer Incidence and Death in Patients With Type 2 Diabetes in Taiwan

  2017cites this paper
• Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation

  2017cites this paper
• Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis

  2017cites this paper
• Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis

  2017influential citation
• Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes.

  2017cites this paper
• Patterns and Prediction of Competing Causes of Mortality in Older Adults Diagnosed with Indolent Non-Hodgkin Lymphoma

  2017cites this paper
• Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer.

  2016cites this paper
• Assessing Quality of Non-Cancer Chronic Care and Medication Adherence for Comorbidities Among Prostate Cancer Survivors

  2016cites this paper
• Breaking the Silos: Integrated Care for Cancer and Chronic Conditions

  2016cites this paper
• Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors

  2016influential citation
• Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors.

  2016cites this paper
• Effects of breast cancer on chronic disease medication adherence among older women

  2016cites this paper
• Nonadherence to Oral Medications for Chronic Conditions in Breast Cancer Survivors.

  2016cites this paper
• Oral antidiabetic drug use and associated health outcomes in cancer patients

  2016cites this paper
• Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes

  2015influential citation
• Chronic disease outcomes among older women with breast cancer in the united states

  2015influential citation
• Diabetes and cancer - a dangerous liaison? : The reciprocal impact of diabetes and cancer on outcomes with a special focus on drug effects

  2015cites this paper
• Associations between diabetes medication use and risk of second breast cancer events and mortality

  2015cites this paper
• Changes in Medication Management After a Diagnosis of Cancer Among Medicare Beneficiaries With Diabetes.

  2015cites this paper
• Comorbidities and Their Management: Potential Impact on Breast Cancer Outcomes.

  2015cites this paper